High oxidative stress and chronic inflammation can contribute to the pathogenesis of coronary heart disease. Cardiovascular diseases are the leading cause of death in the world and hyperlipidemia is an important risk factor for these diseases. Higher levels of low-density lipoprotein cholesterol (LDL-C) may increase the incidence of cardiovascular disease (2).
Recently, coenzyme Q10 has been shown to have a cardio-protective impact on these diseases. A higher level of coenzyme Q10 in the plasma (≥ 0.52 mmol / l) was significantly associated with a reduced risk (3).
It is found, together with alpha tocopherol, in royal jelly of bees (4).
References_________________________________
(1) Effects of Coenzyme Q10 on Markers of Inflammation: A Systematic Review and Meta-Analysis
Junya Zhai, Yacong Bo, Yan Lu, Chunli Liu, Lishi Zhang
PLoS One. 2017; 12(1): e0170172. Published online 2017 Jan 26. doi: 10.1371/journal.pone.0170172
(2) Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial
Bor-Jen Lee, Yu-Fen Tseng, Chi-Hua Yen, Ping-Ting Lin
Nutr J. 2013; 12: 142. Published online 2013 Nov 6. doi: 10.1186/1475-2891-12-142
(3) Lee BJ, Lin YC, Huang YC, Ko YW, Hsia S, Lin PT. The relationship between coenzyme Q10 and oxidative stress, antioxidant enzymes activities and coronary artery disease. ScientificWorldJournal. 2012;2012:792756.
(4) LC/MS/MS analysis of α-tocopherol and coenzyme Q10 content in lyophilized royal jelly, beebread and drone homogenate.
Hryniewicka M, Karpinska A, Kijewska M, Turkowicz MJ, Karpinska J.
J Mass Spectrom. 2016 Nov;51(11):1023-1029. doi: 10.1002/jms.3821.